ATE442864T1 - Pharmazeutische zusammensetzung mit einem organopolysiloxan-elastomer und einem lösungsmittel-aktivwirkstoff - Google Patents
Pharmazeutische zusammensetzung mit einem organopolysiloxan-elastomer und einem lösungsmittel-aktivwirkstoffInfo
- Publication number
- ATE442864T1 ATE442864T1 AT06778599T AT06778599T ATE442864T1 AT E442864 T1 ATE442864 T1 AT E442864T1 AT 06778599 T AT06778599 T AT 06778599T AT 06778599 T AT06778599 T AT 06778599T AT E442864 T1 ATE442864 T1 AT E442864T1
- Authority
- AT
- Austria
- Prior art keywords
- organopolysiloxane elastomer
- pharmaceutical composition
- solvent active
- solvent
- active
- Prior art date
Links
- 229920001971 elastomer Polymers 0.000 title abstract 2
- 239000000806 elastomer Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229920001296 polysiloxane Polymers 0.000 title abstract 2
- 239000002904 solvent Substances 0.000 title 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 229930003316 Vitamin D Natural products 0.000 abstract 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract 1
- 230000000975 bioactive effect Effects 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 208000017520 skin disease Diseases 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
- 235000019166 vitamin D Nutrition 0.000 abstract 1
- 239000011710 vitamin D Substances 0.000 abstract 1
- -1 vitamin D compound Chemical class 0.000 abstract 1
- 229940046008 vitamin d Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0506183A FR2887150B1 (fr) | 2005-06-17 | 2005-06-17 | Composition pharmaceutique comprenant un elastomere organopolysiloxane et un principe actif solubilise |
| PCT/FR2006/001357 WO2006134272A1 (fr) | 2005-06-17 | 2006-06-15 | Composition pharmaceutique comprenant un elastomere organopolysiloxane et un principe actif solubilise |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE442864T1 true ATE442864T1 (de) | 2009-10-15 |
Family
ID=35559477
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06778599T ATE442864T1 (de) | 2005-06-17 | 2006-06-15 | Pharmazeutische zusammensetzung mit einem organopolysiloxan-elastomer und einem lösungsmittel-aktivwirkstoff |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20080194528A1 (de) |
| EP (1) | EP1893237B1 (de) |
| JP (1) | JP2008543815A (de) |
| AT (1) | ATE442864T1 (de) |
| BR (1) | BRPI0613276A2 (de) |
| CA (1) | CA2611869A1 (de) |
| CY (1) | CY1109507T1 (de) |
| DE (1) | DE602006009259D1 (de) |
| DK (1) | DK1893237T3 (de) |
| ES (1) | ES2331811T3 (de) |
| FR (1) | FR2887150B1 (de) |
| PL (1) | PL1893237T3 (de) |
| PT (1) | PT1893237E (de) |
| SI (1) | SI1893237T1 (de) |
| WO (1) | WO2006134272A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8263580B2 (en) | 1998-09-11 | 2012-09-11 | Stiefel Research Australia Pty Ltd | Vitamin formulation |
| CA2611147C (en) | 2005-06-01 | 2013-04-09 | Stiefel Research Australia Pty Ltd. | Topical emulsion formulation |
| WO2009009135A1 (en) | 2007-07-11 | 2009-01-15 | Dow Corning Corporation | Compositions for delivering a drug |
| KR20110056516A (ko) * | 2008-09-12 | 2011-05-30 | 크리티컬 파머수티컬스 리미티드 | 점막 또는 피부를 통한 치료제의 흡수 개선 |
| JP2012513387A (ja) * | 2008-12-23 | 2012-06-14 | ガルデルマ・ソシエテ・アノニム | 感水性の活性成分を含む、局所用医薬組成物 |
| US20100322875A1 (en) | 2009-06-18 | 2010-12-23 | Advanced Bio-Technologies, Inc. | Silicone scar treatment preparation |
| GB0919650D0 (en) | 2009-11-10 | 2009-12-23 | Futura Medical Developments Ltd | Pharmaceutical composition |
| MX2012007229A (es) * | 2009-12-22 | 2012-07-30 | Leo Pharma As | Composicion cutanea que comprende analogo de vitamina d y mezcla de solvente y tensioactivos. |
| AU2010335656B2 (en) * | 2009-12-22 | 2015-05-07 | Leo Pharma A/S | Pharmaceutical composition comprising solvent mixture and a vitamin D derivative or analogue |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3943248A (en) * | 1974-11-04 | 1976-03-09 | Shulman Max J | Methods of treating burns using colophony containing preparations |
| US6538039B2 (en) * | 1994-04-29 | 2003-03-25 | Laboratoire L. Lafon | Pharmaceutical dosage form for transdermal administration |
| FR2719220A1 (fr) * | 1994-04-29 | 1995-11-03 | Lafon Labor | Nouvelle forme galénique pour l'administration transdermique. |
| FR2740038B1 (fr) * | 1995-10-20 | 1998-01-02 | Lafon Labor | Composition pour l'administration transdermique |
| US6103250A (en) * | 1999-07-06 | 2000-08-15 | Revlon Consumer Products Corporation | Anhydrous cosmetic compositions containing emulsifying siloxane elastomer |
| US6924400B2 (en) * | 2001-12-10 | 2005-08-02 | Galderma Research & Development, Snc | Triaromatic vitamin D analogues |
| AU2003267346B2 (en) * | 2002-08-27 | 2010-06-24 | Galderma Research & Development, S.N.C. | Analogues of vitamin D |
| FR2843962B1 (fr) * | 2002-08-27 | 2005-12-02 | Galderma Res & Dev | Analogues de la vitamine d |
| WO2004028515A1 (en) * | 2002-09-26 | 2004-04-08 | Young-Kweon Choi | Matrix type patch for transdermal administration of vitamin d analog and the use thereof |
| BRPI0406490A (pt) * | 2003-02-05 | 2005-12-06 | Galderma Res & Dev | Composições, composição cosmética ou dermatológica e uso de uma composição |
| JP2007511578A (ja) * | 2003-11-21 | 2007-05-10 | ガルデルマ・リサーチ・アンド・デヴェロップメント・エス・エヌ・セ | ビタミンｄの投与のためのスプレー可能な組成物 |
| FR2871695B1 (fr) * | 2004-06-17 | 2008-07-04 | Galderma Sa | Composition pharmaceutique comprenant un agent silicone et deux principes actifs solubilises |
-
2005
- 2005-06-17 FR FR0506183A patent/FR2887150B1/fr not_active Expired - Fee Related
-
2006
- 2006-06-15 PT PT06778599T patent/PT1893237E/pt unknown
- 2006-06-15 CA CA002611869A patent/CA2611869A1/fr not_active Abandoned
- 2006-06-15 DE DE602006009259T patent/DE602006009259D1/de active Active
- 2006-06-15 SI SI200630410T patent/SI1893237T1/sl unknown
- 2006-06-15 AT AT06778599T patent/ATE442864T1/de active
- 2006-06-15 PL PL06778599T patent/PL1893237T3/pl unknown
- 2006-06-15 EP EP06778599A patent/EP1893237B1/de not_active Not-in-force
- 2006-06-15 WO PCT/FR2006/001357 patent/WO2006134272A1/fr not_active Ceased
- 2006-06-15 DK DK06778599T patent/DK1893237T3/da active
- 2006-06-15 JP JP2008516377A patent/JP2008543815A/ja active Pending
- 2006-06-15 BR BRPI0613276-6A patent/BRPI0613276A2/pt not_active IP Right Cessation
- 2006-06-15 ES ES06778599T patent/ES2331811T3/es active Active
-
2007
- 2007-12-17 US US12/000,773 patent/US20080194528A1/en not_active Abandoned
-
2009
- 2009-10-22 CY CY20091101102T patent/CY1109507T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2611869A1 (fr) | 2006-12-21 |
| FR2887150A1 (fr) | 2006-12-22 |
| PT1893237E (pt) | 2009-11-03 |
| BRPI0613276A2 (pt) | 2010-12-28 |
| US20080194528A1 (en) | 2008-08-14 |
| PL1893237T3 (pl) | 2010-02-26 |
| EP1893237B1 (de) | 2009-09-16 |
| DE602006009259D1 (de) | 2009-10-29 |
| ES2331811T3 (es) | 2010-01-15 |
| JP2008543815A (ja) | 2008-12-04 |
| EP1893237A1 (de) | 2008-03-05 |
| WO2006134272A1 (fr) | 2006-12-21 |
| SI1893237T1 (sl) | 2010-03-31 |
| DK1893237T3 (da) | 2009-11-09 |
| CY1109507T1 (el) | 2014-08-13 |
| FR2887150B1 (fr) | 2007-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1109507T1 (el) | Φαρμακευτικη συνθεση η οποια περιλαμβανει ενα ελαστομερες οργανοπολυσιλοξανιο και μια διαλυτοποιημενη δραστικη ουσια | |
| CO5640037A2 (es) | Derivados de la quinazolina para el tratamiento del cancer | |
| EP4442241A3 (de) | Retinolersatz zur hautbehandlung | |
| BRPI0510428A (pt) | composições tópicas de metadona e processos para utilização das mesmas | |
| BR0312573A (pt) | Derivados de fenil-[4-(3-fenil-1h-pirazol-4-il)-pirimidin-2-il]-amina | |
| ATE361084T1 (de) | Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis | |
| CL2008000442A1 (es) | Composicion farmaceutica que comprende a un quitosano, un ingrediente activo cosmetico o farmaceutico, y un solvente volatil; y su uso para tratar psoriasis, micosis entre otras enfermedades. | |
| CR10838A (es) | Derivados de 2,3-dihidroimidazol [1,2-c] quinazolina sustituidos, de utilidad en el tratamiento de trastornos hiperproliferativos y enfermedades asociadas con la angiogenesis | |
| IL154888A (en) | Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid | |
| EP2144608A4 (de) | Sonnenschutzzusammensetzungen und verfahren | |
| CY1108932T1 (el) | Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων | |
| CL2008002747A1 (es) | Compuestos derivados de furo y tienopirimidina; composicion farmaceutica; metodo para modular la actividad del receptor de histamina h4; y uso en el tratamiento de trastornos tales como inflamacion, trastornos alergicos, dermatologicos, entre otros. | |
| AR049518A1 (es) | Composicion farmaceutica que comprende un agente siliconado y dos principios activos solubilizados | |
| BRPI0416311A (pt) | composição, uso de uma composição e processo para melhorar a penetração de um agente ativo farmacêutico | |
| EA200702204A1 (ru) | Лечение заболеваний соединительной ткани кожи | |
| UY29561A1 (es) | Derivados de quinazolina, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones | |
| WO2004100893A3 (en) | Methods for treatment of inflammatory diseases using ct-3 or analogs thereof | |
| DE602005016803D1 (de) | Zusammensetzungen mit strontium und vitamin d und ihre verwendungen | |
| TNSN07203A1 (en) | Pharmaceutical compositions for the treatment of cellulite | |
| CA2494473A1 (en) | Stabilized protein compositions for topical administration and methods of making same | |
| CY1111361T1 (el) | Νεα προσδεματα συναγωνιστες των υποδοχεων rar, χρηση στην ανθρωπινη ιατρικη καθως και στην κοσμετολογια | |
| AR057648A1 (es) | Composicion de metaflumizona para la administracion topica | |
| DK1699468T3 (da) | Farmaceutisk sammensætning, der omfatter et zink-hyaluronatkompleks, til behandling af dissemineret skelrose | |
| SE0203817D0 (sv) | New composition | |
| DK1620116T3 (da) | Anvendelse af cinchona til fremstilling af et l gemiddel, som stimulerer angiogenese |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1893237 Country of ref document: EP |